Centre de recherche clinique Étienne LeBel, Centre hospitalier universitaire de Sherbrooke, Université de Sherbrooke, 3001 12th Avenue Nord, Sherbrooke, Quebec, Canada.
Metab Syndr Relat Disord. 2011 Jun;9(3):225-9. doi: 10.1089/met.2010.0101. Epub 2011 Mar 1.
Obesity and the metabolic syndrome are significant determinants of functional capacity in women. In the past decade, the term "metabolically healthy obese" (MHO) emerged in the literature to identify a distinct category of obese individuals presenting less metabolic impairment than expected. However, MHO women might have similar risk than non-MHO women for nonmetabolic weight-related co-morbidities, including altered functional capacity.
Eighty six obese women aged from 28 to 74 years old were studied. MHO was defined as a body mass index (BMI) ≥30.0 kg/m(2) with less than one metabolic syndrome criteria based on the Adult Treatment Panel III (ATP III) definition. Walking distance (m) and walking speed (m/sec), evaluated by the 6-min walk test, were used as indicators of functional capacity.
Twenty one percent of the sample was considered MHO. Age, BMI, physical activity level, and diastolic blood pressure were not significantly different between MHO and non-MHO women. MHO women performed better on the 6-min walk test (519.8 m±68.2 vs. 448.4 m±67.1; P≤0.01) compared to non-MHO women. Moreover, in multiple regression analyses, MHO status and BMI were significantly associated with walking speed after adjustment for age, physical activity level, the total number of chronic conditions, and arthritis/osteoarthritis.
Our results show that MHO women have a better functional capacity than non-MHO women, and therefore could be at lower risk for future disability. However, weight management remains important because BMI was also an independent predictor of functional capacity regardless of metabolic profile.
肥胖和代谢综合征是女性身体功能能力的重要决定因素。在过去的十年中,“代谢健康型肥胖”(MHO)一词在文献中出现,以确定一类代谢异常程度低于预期的肥胖个体。然而,与非 MHO 女性相比,MHO 女性可能具有相似的非代谢相关体重合并症风险,包括身体功能能力的改变。
研究了 86 名年龄在 28 岁至 74 岁之间的肥胖女性。MHO 的定义为体质指数(BMI)≥30.0kg/m2,且根据成人治疗小组 III(ATP III)的定义,少于一项代谢综合征标准。6 分钟步行测试评估的步行距离(m)和步行速度(m/sec)被用作身体功能能力的指标。
21%的样本被认为是 MHO。年龄、BMI、身体活动水平和舒张压在 MHO 和非 MHO 女性之间没有显著差异。MHO 女性在 6 分钟步行测试中的表现优于非 MHO 女性(519.8m±68.2 vs. 448.4m±67.1;P≤0.01)。此外,在多元回归分析中,在调整年龄、身体活动水平、慢性疾病总数和关节炎/骨关节炎后,MHO 状态和 BMI 与步行速度显著相关。
我们的研究结果表明,MHO 女性的身体功能能力优于非 MHO 女性,因此可能未来残疾的风险较低。然而,体重管理仍然很重要,因为 BMI 也是身体功能能力的独立预测因素,与代谢状况无关。